Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group.
Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, Chuncharunee S, Niparuck P, Numbenjapon T, Prayongratana K, Kanitsap N, Wongkhantee S, Makruasi N, Wong P, Norasetthada L, Nawarawong W, Sirijerachai C, Chansung K, Suwanban T, Praditsuktavorn P, Intragumtornchai T; Thai Lymphoma Study Group. Wudhikarn K, et al. Among authors: praditsuktavorn p. J Geriatr Oncol. 2020 Jan;11(1):62-68. doi: 10.1016/j.jgo.2019.03.016. Epub 2019 Mar 30. J Geriatr Oncol. 2020. PMID: 30940492
Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry.
Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Chuncharunee S, Niparuck P, Ekwattanakit S, Khuhapinant A, Norasetthada L, Nawarawong W, Makruasi N, Kanitsap N, Sirijerachai C, Chansung K, Wong P, Numbenjapon T, Prayongratana K, Suwanban T, Wongkhantee S, Praditsuktavorn P, Intragumtornchai T; Thai Lymphoma Study Group. Wudhikarn K, et al. Among authors: praditsuktavorn p. Ann Hematol. 2017 Jan;96(1):57-64. doi: 10.1007/s00277-016-2848-y. Epub 2016 Oct 18. Ann Hematol. 2017. PMID: 27752821
Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma.
Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, Niparuck P, Chuncharunee S, Numbenjapon T, Prayongratana K, Kanitsap N, Wongkhantee S, Makruasri N, Wong P, Norasetthada L, Nawarawong W, Sirijerachai C, Chansung K, Suwanban T, Praditsuktavorn P, Intragumtornchai T; Thai Lymphoma Study Group. Wudhikarn K, et al. Among authors: praditsuktavorn p. Hematol Oncol. 2019 Dec;37(5):578-585. doi: 10.1002/hon.2687. Epub 2019 Nov 12. Hematol Oncol. 2019. PMID: 31702065
Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group.
Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, Niparuck P, Chuncharunee S, Numbenjapon T, Prayongratana K, Kanitsap N, Wongkhantee S, Makruasi N, Wong P, Norasetthada L, Nawarawong W, Sirijerachai C, Chansung K, Suwanban T, Praditsuktavorn P, Intragumtornchai T. Wudhikarn K, et al. Among authors: praditsuktavorn p. Leuk Lymphoma. 2020 Nov;61(11):2614-2621. doi: 10.1080/10428194.2020.1780586. Epub 2020 Jun 23. Leuk Lymphoma. 2020. PMID: 32573294
Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma.
Tang T, Chen Z, Praditsuktavorn P, Khoo LP, Ruan J, Lim ST, Tan D, Phipps C, Lee YS, Goh YT, Hwang W, Tao M, Quek R, Farid M, Furman RR, Leonard JP, Martin P. Tang T, et al. Among authors: praditsuktavorn p. Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):117-21. doi: 10.1016/j.clml.2015.12.006. Epub 2015 Dec 21. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26796979
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors.
Cayrol F, Praditsuktavorn P, Fernando TM, Kwiatkowski N, Marullo R, Calvo-Vidal MN, Phillip J, Pera B, Yang SN, Takpradit K, Roman L, Gaudiano M, Crescenzo R, Ruan J, Inghirami G, Zhang T, Cremaschi G, Gray NS, Cerchietti L. Cayrol F, et al. Among authors: praditsuktavorn p. Nat Commun. 2017 Jan 30;8:14290. doi: 10.1038/ncomms14290. Nat Commun. 2017. PMID: 28134252 Free PMC article.
Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors.
Cayrol F, Praditsuktavorn P, Fernando TM, Kwiatkowski N, Marullo R, Calvo-Vidal MN, Phillip J, Pera B, Yang SN, Takpradit K, Roman L, Gaudiano M, Crescenzo R, Ruan J, Inghirami G, Zhang T, Cremaschi G, Gray NS, Cerchietti L. Cayrol F, et al. Among authors: praditsuktavorn p. Nat Commun. 2017 Feb 20;8:14747. doi: 10.1038/ncomms14747. Nat Commun. 2017. PMID: 28218232 Free PMC article. No abstract available.
Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group.
Thanhakun R, Wudhikarn K, Bunworasate U, Rattanathammethee T, Norasetthada L, Kanya P, Chaloemwong J, Wongkhantee S, Phiphitaporn P, Chansung K, Jit-Ueakul D, Laoruangroj C, Prayongratana K, Wong P, Julamanee J, Lekhakula A, Chuncharunee S, Niparuck P, Kanitsap N, Makruasi N, Suwanban T, Praditsuktavorn P, Khuhapinant A, Intragumtornchai T; Thai Lymphoma Study Group. Thanhakun R, et al. Among authors: praditsuktavorn p. Ann Hematol. 2023 Dec;102(12):3533-3541. doi: 10.1007/s00277-023-05437-6. Epub 2023 Sep 18. Ann Hematol. 2023. PMID: 37718327
Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies.
Thookhamme C, Navinpipat M, Sasakul A, Pattarakosol P, Lertchaisataporn K, Tawinprai K, Praditsuktavorn P. Thookhamme C, et al. Among authors: praditsuktavorn p. Clin Exp Vaccine Res. 2023 Apr;12(2):107-115. doi: 10.7774/cevr.2023.12.2.107. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214149 Free PMC article.